About
Focus
Pipeline
Patients
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
About
Focus
Pipeline
Patients
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
European Society of Medical Oncology 2017 Congress
European Society of Medical Oncology 2017 Congress
September 2017
A Phase 1 Dose Finding Study of X4P-001 (An Oral CXCR4 Inhibitor) and Axitinib in Patients with Advanced Renal Cell Carcinoma
© 2023 X4 Pharmaceuticals, Inc. All rights reserved.
Terms of Use
|
Privacy Policy